Delivery Order SPE2DR25D1201-SPE2DR26FAJPE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $37,329.50 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on September 4, 2025, with completion targeted for September 5, 2025. This non-competed, firm fixed-price delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $19,336.06 for NURTEC ODT 75 mg tablets (8-count units). This firm fixed price, non-set-aside contract was competitively awarded on September 15, 2025, with an ultimate completion date of September 16, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 29, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply NURTEC ODT 75 mg tablets (8-count units) under a firm fixed-price contract valued at $9,259.00. The order is scheduled for completion by September 2, 2025, and will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation and represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $13,408.48 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count packages) on September 23, 2025, with completion scheduled for September 24, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $28,177.74 on August 29, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages). This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by September 2, 2025, with performance executed from the contractor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 18, 2025, for NURTEC ODT 75 mg tablets (8-count units) with a ceiling value of $36,255.24. The contract employs firm fixed pricing and is classified as a non-competitive delivery order, with an ultimate completion date of August 19, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $1,231.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count). This contract, which is a child award under a larger vehicle, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $17,511.43 by the Defense Logistics Agency (DLA) to supply NURTEC ODT 75 mg tablets in quantities of 8 units. The contract, awarded on June 18, 2025, utilizes firm fixed pricing with an ultimate completion date of June 20, 2025, and represents a non-competitive set-aside order. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count packages). This competitive, non-set-aside contract is valued at $70,553.66 with firm fixed pricing and an ultimate completion date of September 29, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $47,868.59 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on October 24, 2025, with an ultimate completion date of October 27, 2025. This delivery order represents a firm fixed-price, non-set-aside competitive award issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026....
- SPE2DR25D1201Indefinite Delivery Contract
- SPE2DR25D1201-SPE2DR26FAJPEDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $23,477.61 by the Defense Logistics Agency on October 24, 2025, for the supply of NURTEC ODT 75 mg tablets (8 count). This firm fixed-price contract, with an ultimate completion date of October 27, 2025, represents a competitively awarded, non-set-aside procurement supporting federal medical supply needs. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The delivery order fulfills the Defense Logistics Agency's requirement for NURTEC ODT, a migraine treatment medication, supporting the Defense Health Agency and broader military medical supply chain operations. As a child delivery order under AmerisourceBergen's prime IDC vehicle, this award demonstrates the contractor's continued capability to meet federal pharmaceutical procurement requirements through the competitive open market process. The DLA Medical Supply Chain relies on AmerisourceBergen's extensive portfolio to distribute specialized medications and medical commodities across multiple therapeutic domains to support military personnel and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.5k | 10/24/25 |